Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Middle East Healthcare CoSAU:4009 +0.60%79 PEG Ratio is 0.49 as of Jul. 24, 2026, which is 54% below its 10-year median of 1.07. GuruFocus rates SAU:4009 with a GF Score™ of 79/100 and a GF Value™ of ﷼80.23 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 226 Healthcare Providers & Services companies, Middle East Healthcare Co ranks better than 84.51% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Middle East Healthcare Co's PEG Ratio or its related term are showing as below:
SAU:4009'
s PEG Ratio Range Over the Past 10 Years
Min: 0.32 Med: 1.07 Max: 107.65
Current: 0.49
During the past 11 years, Middle East Healthcare Co's highest PEG Ratio was 107.65. The lowest was 0.32. And the median was 1.07.
SAU:4009's PEG Ratio is ranked better than 84.51% of 226
companies
in the Healthcare Providers & Services industry
Industry Median: 1.35
vs SAU:4009: 0.49
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Middle East Healthcare Co (SAU:4009) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Middle East Healthcare Co PEG Ratio Related Terms
Middle East Healthcare Co PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Middle East Healthcare Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Middle East Healthcare Co PEG Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Middle East Healthcare Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Middle East Healthcare Co's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Middle East Healthcare Co (SAU:4009) has a PEG Ratio of 0.49 as of Jul. 24, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Middle East Healthcare Co and its competitors. This is 54% below median its historical median of 1.07. Over the past decade, Middle East Healthcare Co's PEG Ratio has ranged from 0.32 to 107.65. According to the industry distribution chart, Middle East Healthcare Co ranks #35 out of 226 companies in the Healthcare Providers & Services industry, placing it in the top 15.5%.
Is Middle East Healthcare Co's PEG Ratio too high?
Middle East Healthcare Co's current PEG Ratio of 0.49 is 54% below median its 10-year median of 1.07. Over the past 10 years, this metric has ranged from a low of 0.32 to a high of 107.65. The Healthcare Providers & Services industry median PEG Ratio is 1.35. Middle East Healthcare Co's value of 0.49 is 63.7% below this industry median. Based on the distribution chart, Middle East Healthcare Co ranks #35 out of 226 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Middle East Healthcare Co has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Middle East Healthcare Co's PEG Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Middle East Healthcare Co ranks #35 out of 226 companies for PEG Ratio. This places Middle East Healthcare Co in the top 16% of its industry — outperforming the majority of peers. The industry median PEG Ratio is 1.35. Middle East Healthcare Co's value of 0.49 is 63.7% below this benchmark. Historically, Middle East Healthcare Co's own PEG Ratio has ranged from 0.32 to 107.65 over the past decade. While the company's 10-year median is 1.07 vs. the industry median of 1.35, Middle East Healthcare Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Healthcare Providers & Services company?
The median PEG Ratio among Healthcare Providers & Services companies is 1.35, based on 226 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Middle East Healthcare Co's current PEG Ratio of 0.49 is 63.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Middle East Healthcare Co and its competitors. For the Healthcare Providers & Services industry, the median PEG Ratio is 1.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Middle East Healthcare Co's current PEG Ratio is 0.49, which is 54% below median its own 10-year median of 1.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Middle East Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Middle East Healthcare Co (SAU:4009) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼80.23, compared to a current price of ﷼30.28 — trading 62.3% below its estimated fair value. The current PEG Ratio is 0.49, which is 54% below median its 10-year median of 1.07 and 63.7% below the Healthcare Providers & Services industry median of 1.35. Middle East Healthcare Co's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Middle East Healthcare Co (SAU:4009), the current PEG Ratio is 0.49 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Middle East Healthcare Co (SAU:4009) Overvalued in 2026?
Based on GuruFocus' analysis, Middle East Healthcare Co stock appears to be undervalued.
The current stock price of ﷼30.28 is trading 62.3% below its estimated GF Value™ of ﷼80.23.
GuruFocus considers Middle East Healthcare Co to be Possible Value Trap.
Key valuation signals for SAU:4009:
PEG Ratio: 0.49 (54% below median its 10-year median of 1.07)
GF Value™: ﷼80.23 vs. price of ﷼30.28 (62.3% below fair value)
Industry Position: 63.7% below the Healthcare Providers & Services median (#35 of 226)
No single metric tells the full story. See the SAU:4009 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Middle East Healthcare Co is a Saudi Arabia-based company engaged in the business of managing, operating and maintaining hospitals, medical centers, educational centers, rehabilitation centers, physiotherapy, laboratories and radiology centers, pharmacies, construction, and to buy land for the purpose of constructing medical projects and to establish, manage and organize exhibitions for the company. The company's reportable segments are Inpatient Services, Outpatient Services, Pharmacy Sales and Others. The majority of revenue is derived from the Inpatient Services segment.
79GF Score
Get the complete analysis for SAU:4009
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4009 has been successfully added to your 
